Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25
Always consult with a healthcare provider before starting any new supplement or medication
ABSTRACT Obesity is a significant risk factor for health issues like type 2 diabetes and cardiovascular disease
We do not claim affiliation with or endorsement by Novo Nordisk
Improves heart health Weight loss injections are known for their cardioprotective effects, especially in people with type 2 diabetes
(Nasdaq: LEXX & LEXXW) (the Company or Lexaria), a global innovator in drug delivery platforms announces additional positive interim results from a human pilot study (the Study) evaluating DehydraTECHTM technology for the oral delivery of the glucagon-like peptide-1 (GLP-1) drug semaglutide available commercially in the branded product Rybelsus, further to its previously announced findings from this work
Consumers have no way to verify what they're actually getting, what dose they're taking, or what contaminants might be present
